Cardiovascular & Respiratory Medicines

The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")

This public procurement record has 2 releases in its history.

Award

07 Apr 2021 at 01:00

Tender

17 Nov 2020 at 00:00

Summary of the contracting process

The procurement process is conducted by The Common Services Agency, commonly known as NHS National Services Scotland, for a Framework Agreement titled "Cardiovascular & Respiratory Medicines." This procurement falls under the health industry category and is based in Edinburgh, UK. The current stage of the tender is "Award," with a total value of £19,491,306. The tender period concluded on 21st December 2020, leading into the award phase. This framework agreement aims to supply various cardiovascular and respiratory medicines across NHS Scotland, divided into fifteen specific categories or lots, each delineating the requirements for suppliers.

This tender presents significant opportunities for businesses engaged in the healthcare and pharmaceutical sectors, particularly for those specialising in the manufacture and distribution of respiratory and cardiovascular medicines. Companies with capabilities in logistics and quality management would be well-suited to compete. The open procurement method allows for multiple suppliers to participate, enhancing the chances for both established and emerging companies in the health industry to engage with Scotland's health boards and contribute to vital public health services.

How relevant is this notice?

Notice Title

Cardiovascular & Respiratory Medicines

Notice Description

This Framework Agreement is for the supply of Cardiovascular & Respiratory Medicines to health boards across NHS Scotland. The Goods have been split into fifteen (15) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.

Lot Information

Epoprostenol powder and solvent (pH10.5) for solution for infusion vials

Supply of Epoprostenol 500mcg and 1.5mg powder and solvent (pH10.5) for solution for infusion vials to NHS Scotland. The Authority has awarded all products within this lot to a single supplier.

Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.

Epoprostenol powder and solvent (pH12) for solution for infusion vials

Supply of Epoprostenol 500mcg and 1.5mg powder and solvent (pH12) for solution for infusion vials to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.

Epinephrine (Adrenaline) Pre-filled syringes

Supply of Epinephrine (Adrenaline) Pre-filled syringes to NHS Scotland in a range of presentations. The Authority has awarded each product line to a single supplier.

Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.

Epinephrine (Adrenaline) Auto Injector Devices

Supply of Epinephrine (Adrenaline) Auto Injector Devices to NHS Scotland in a range of presentations. The Authority has awarded each product line to a single supplier.

Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.

Fondaparinux Sodium Pre-filled Syringes

Supply of Fondaparinux Sodium Pre-filled Syringes to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement to two (2) Framework Participants.

Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.

Urokinase Injections

Supply of Urokinase Injections to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Suppliers will be awarded. Full details can be found within the ITT.

Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire

Isosorbide Mononitrate Modified Release Capsules and Tablets

Supply of Isosorbide Mononitrate Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement to six (6) Framework Participants.

Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.

Diltiazem Hydrochloride Modified Release Capsules and Tablets

Supply of Diltiazem Hydrochloride Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement to six (6) Framework Participants.

Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.

Verapamil Hydrochloride Modified Release Capsules and Tablets

Supply of Verapamil Hydrochloride Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line to a single supplier.

Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.

Nifedipine Modified Release Capsules and Tablets

Supply of Nifedipine Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement to three (3) Framework Participants.

Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.

Theophylline Modified Release Capsules and Tablets

Supply of Theophylline Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line to a single supplier.

Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.

Bosentan Tablets

Supply of Bosentan Tablets to NHS Scotland. The Authority has awarded this Lot as a multi-supplier unranked framework to five (5) Framework Participants.

Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.

Branded and Branded Generic Inhalers

Supply of Branded and Branded Generic Inhalers to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement to six (6) Framework Participants.

Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.

All other Cardiovascular & Respiratory Medicines

Supply of all other Cardiovascular & Respiratory Medicines to NHS Scotland in a range of presentations. The Authority has awarded each line within this lot to a single supplier.

Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.

Iloprost Medicines

Supply of Iloprost Solutions for Infusion and Nebuliser solutions, to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi supplier unranked framework agreement on a line by line basis to three (3) suppliers.

Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire

Publication & Lifecycle

Open Contracting ID
ocds-r6ebe6-0000635950
Publication Source
Public Contracts Scotland
Latest Notice
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=APR411459
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
OJEU - F3 - Contract Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£19,491,306 £10M-£100M
Lots Value
£19,491,306 £10M-£100M
Awards Value
Not specified
Contracts Value
£105,516,940 £100M-£1B

Notice Dates

Publication Date
7 Apr 20215 years ago
Submission Deadline
21 Dec 2020Expired
Future Notice Date
Not specified
Award Date
4 Mar 20215 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Active, Complete
Awards Status
Not Specified
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
EDINBURGH
Postcode
EH12 9EB
Postcode Area
Edinburgh
Country
Scotland

Major Region (ITL 1)
TLM Scotland
Basic Region (ITL 2)
TLM1 East Central Scotland
Small Region (ITL 3)
TLM13 City of Edinburgh
Delivery Location
TLM Scotland

Local Authority
City of Edinburgh
Electoral Ward
Drum Brae/Gyle
Westminster Constituency
Edinburgh South West

Supplier Information

Number of Suppliers
43
Supplier Names

Accord Healthcare Ltd

Aguettant Ltd

Aspire Pharma Ltd

Aventis Pharma Ltd Trading As Sanofi

Baxter Healthcare Ltd

Bowmed Ibisqus Limited

Brown and Burk

Chiesi Limited

Cipla (EU) Ltd

Colonis Pharma Ltd

Consilient Health Ltd

Correvio GmbH

Crescent Pharma Limited

Dr Reddy's Laboratories (UK) Ltd

Ennogen Healthcare Ltd

Firstline Pharma Ltd

Focus Pharmaceuticals Ltd

Galen Ltd

GlaxoSmithKline

Glenmark Pharmaceuticals Europe Ltd

Intrapharm Laboratories Ltd

Kent Pharmaceuticals Ltd

Martindale Pharma

Mercury Pharma Group

Morningside Pharmaceuticals Limited

Mylan

Napp Pharmaceuticals

Norgine Pharmaceuticals Limited

Organon Pharmaceutical UK Ltd

Pfizer Ltd

Ranbaxy (UK) Ltd

Rosemont Pharmaceuticals Ltd

Sandoz Ltd

Selective Supplies Ltd

Sintetica Limited

Synchrony Pharma Ltd

Syri Limited T/A Thame Laboratories

Teva UK Limited

Thornton & Ross Ltd

Torrent Pharma (UK) Ltd

Wockhardt UK Limited

Zentiva Pharma UK Ltd

hameln pharmaceuticals ltd

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...